CytoSorbents Execs to Present at H.C. Wainwright Investor Conference
Princeton, N.J. – – September 15, 2026 -- CytoSorbents Corporation (NASDAQ: CTSO) will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City from September 14–16, 2026, as the blood-purification device maker seeks to update investors on its regulatory pipeline and path to profitability.
CEO and CFO to join fireside chat on September 14
Dr. Phillip Chan, Chief Executive Officer, and Peter Mariani, Chief Financial Officer, will join Sean Lee, Vice President of Equity Research at H.C. Wainwright, for a fireside chat at 11:30 a.m. EDT at the Lotte New York Palace Hotel. The two executives will also hold scheduled one-on-one meetings with investors during the three-day event. A webcast replay will remain archived for up to 90 days on the company's investor relations site.